Literature DB >> 29729182

Bile Acids, Microbiota, and Metabolism.

Sarah A Taylor1, Richard M Green2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29729182      PMCID： PMC6173626          DOI： 10.1002/hep.30078

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  10 in total

1.  On the transformation and enterohepatic circulation of cholic acid in the rat: bile acids and steroids 68.

Authors:  A NORMAN; J SJOVALL
Journal:  J Biol Chem       Date:  1958-10       Impact factor: 5.157

Review 2.  An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease.

Authors:  Frank J Gonzalez; Changtao Jiang; Andrew D Patterson
Journal:  Gastroenterology       Date:  2016-09-14       Impact factor: 22.682

3.  Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.

Authors:  Preeti Pathak; Hailiang Liu; Shannon Boehme; Cen Xie; Kristopher W Krausz; Frank Gonzalez; John Y L Chiang
Journal:  J Biol Chem       Date:  2017-05-06       Impact factor: 5.157

Review 4.  Microbial metabolites in health and disease: Navigating the unknown in search of function.

Authors:  Kristina B Martinez; Vanessa Leone; Eugene B Chang
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.157

5.  Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.

Authors:  Changtao Jiang; Cen Xie; Fei Li; Limin Zhang; Robert G Nichols; Kristopher W Krausz; Jingwei Cai; Yunpeng Qi; Zhong-Ze Fang; Shogo Takahashi; Naoki Tanaka; Dhimant Desai; Shantu G Amin; Istvan Albert; Andrew D Patterson; Frank J Gonzalez
Journal:  J Clin Invest       Date:  2014-12-15       Impact factor: 14.808

6.  Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.

Authors:  Preeti Pathak; Cen Xie; Robert G Nichols; Jessica M Ferrell; Shannon Boehme; Kristopher W Krausz; Andrew D Patterson; Frank J Gonzalez; John Y L Chiang
Journal:  Hepatology       Date:  2018-05-21       Impact factor: 17.425

Review 7.  Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades.

Authors:  Alan F Hofmann; Lee R Hagey
Journal:  J Lipid Res       Date:  2014-05-17       Impact factor: 5.922

8.  Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance.

Authors:  Sungsoon Fang; Jae Myoung Suh; Shannon M Reilly; Elizabeth Yu; Olivia Osborn; Denise Lackey; Eiji Yoshihara; Alessia Perino; Sandra Jacinto; Yelizaveta Lukasheva; Annette R Atkins; Alexander Khvat; Bernd Schnabl; Ruth T Yu; David A Brenner; Sally Coulter; Christopher Liddle; Kristina Schoonjans; Jerrold M Olefsky; Alan R Saltiel; Michael Downes; Ronald M Evans
Journal:  Nat Med       Date:  2015-01-05       Impact factor: 53.440

9.  Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism.

Authors:  Limin Zhang; Cen Xie; Robert G Nichols; Siu H J Chan; Changtao Jiang; Ruixin Hao; Philip B Smith; Jingwei Cai; Margaret N Simons; Emmanuel Hatzakis; Costas D Maranas; Frank J Gonzalez; Andrew D Patterson
Journal:  mSystems       Date:  2016-10-11       Impact factor: 6.496

10.  Microbiota-induced obesity requires farnesoid X receptor.

Authors:  Ava Parséus; Nina Sommer; Felix Sommer; Robert Caesar; Antonio Molinaro; Marcus Ståhlman; Thomas U Greiner; Rosie Perkins; Fredrik Bäckhed
Journal:  Gut       Date:  2016-01-06       Impact factor: 23.059
  10 in total
  8 in total

1.  Bile acid metabolism and liver fibrosis following treatment with bifid triple viable capsules in nonalcoholic fatty liver disease.

Authors:  Yuqing Zhou; Wen Lu; Guorong Yang; Yifeng Chen; Jiwei Cao; Chunli Zhou
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Dynamic Changes in Microbiome Composition Following Mare's Milk Intake for Prevention of Collateral Antibiotic Effect.

Authors:  Almagul Kushugulova; Ulrike Löber; Saniya Akpanova; Kairat Rysbekov; Samat Kozhakhmetov; Zhanagul Khassenbekova; Morgan Essex; Ayaulym Nurgozhina; Madiyar Nurgaziyev; Dmitriy Babenko; Lajos Markó; Sofia K Forslund
Journal:  Front Cell Infect Microbiol       Date:  2021-04-21       Impact factor: 5.293

3.  Integration of the Human Gut Microbiome and Serum Metabolome Reveals Novel Biological Factors Involved in the Regulation of Bone Mineral Density.

Authors:  Jonathan Greenbaum; Xu Lin; Kuan-Jui Su; Rui Gong; Hui Shen; Jie Shen; Hong-Mei Xiao; Hong-Wen Deng
Journal:  Front Cell Infect Microbiol       Date:  2022-03-16       Impact factor: 5.293

4.  Grape Seed Proanthocyanidin Alleviates Intestinal Inflammation Through Gut Microbiota-Bile Acid Crosstalk in Mice.

Authors:  Yi Wu; Ruixia Mo; Mingrui Zhang; Weiwei Zhou; Defa Li
Journal:  Front Nutr       Date:  2022-01-28

5.  Matcha green tea targets the gut-liver axis to alleviate obesity and metabolic disorders induced by a high-fat diet.

Authors:  Yuefei Wang; Yueer Yu; Lejia Ding; Ping Xu; Jihong Zhou
Journal:  Front Nutr       Date:  2022-08-01

Review 6.  Recent insights into the role of microbiome in the pathogenesis of obesity.

Authors:  Eduard W J van der Vossen; Marcus C de Goffau; Evgeni Levin; Max Nieuwdorp
Journal:  Therap Adv Gastroenterol       Date:  2022-08-09       Impact factor: 4.802

7.  The Proteome of Extracellular Vesicles Produced by the Human Gut Bacteria Bacteroides thetaiotaomicron In Vivo Is Influenced by Environmental and Host-Derived Factors.

Authors:  Régis Stentz; Emily Jones; Rokas Juodeikis; Udo Wegmann; Maria Guirro; Andrew J Goldson; Arlaine Brion; Catherine Booth; Padhmanand Sudhakar; Ian R Brown; Tamás Korcsmáros; Simon R Carding
Journal:  Appl Environ Microbiol       Date:  2022-08-02       Impact factor: 5.005

Review 8.  Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease.

Authors:  Agata Mulak
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.